Page last updated: 2024-08-16

pirinixic acid and 2-naphthol

pirinixic acid has been researched along with 2-naphthol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Greiner, C; Hieke, M; Schubert-Zsilavecz, M; Thieme, TM; Werz, O; Zettl, H	1
Crumrine, D; Elias, PM; Feingold, KR; Fujiwara, S; Hatano, Y; Katagiri, K	1

Other Studies

2 other study(ies) available for pirinixic acid and 2-naphthol

Article	Year
A novel class of dual mPGES-1/5-LO inhibitors based on the α-naphthyl pirinixic acid scaffold. Bioorganic & medicinal chemistry letters, 2011, Mar-01, Volume: 21, Issue:5 Topics: Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Inhibitory Concentration 50; Intramolecular Oxidoreductases; Lipoxygenase Inhibitors; Models, Biological; Molecular Structure; Naphthols; Prostaglandin-E Synthases; Pyrimidines; Structure-Activity Relationship	2011
Efficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis. The Journal of investigative dermatology, 2011, Volume: 131, Issue:9 Topics: Adjuvants, Immunologic; Animals; Clobetasol; Dermatitis, Atopic; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Epidermis; Female; Glucocorticoids; Haptens; Mice; Mice, Hairless; Naphthols; Oxazolone; Peroxisome Proliferators; PPAR alpha; Pyrimidines; Secondary Prevention; Triazines	2011

Article

Year

A novel class of dual mPGES-1/5-LO inhibitors based on the α-naphthyl pirinixic acid scaffold.

Bioorganic & medicinal chemistry letters, 2011, Mar-01, Volume: 21, Issue:5

Topics: Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Inhibitory Concentration 50; Intramolecular Oxidoreductases; Lipoxygenase Inhibitors; Models, Biological; Molecular Structure; Naphthols; Prostaglandin-E Synthases; Pyrimidines; Structure-Activity Relationship

2011

Efficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis.

The Journal of investigative dermatology, 2011, Volume: 131, Issue:9

Topics: Adjuvants, Immunologic; Animals; Clobetasol; Dermatitis, Atopic; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Epidermis; Female; Glucocorticoids; Haptens; Mice; Mice, Hairless; Naphthols; Oxazolone; Peroxisome Proliferators; PPAR alpha; Pyrimidines; Secondary Prevention; Triazines

2011